Gosset Ownership
Private
Employees
~10
Therapeutic Areas
Stage
Phase 2
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Rediscovery Life Sciences General Information
RLS advanced suramin sodium into Phase 2 clinical trials for acute kidney injury. The company’s data contributed to further development efforts after being acquired by PaxMedica for use in other indications such as African Sleeping Sickness. No additional programs or results are publicly disclosed.
Contact Information
Primary Industry
Biotech
Corporate Office
Cambridge, Massachusetts
United States
United States
Drug Pipeline
suramin
Phase 2Key Partnerships
Rediscovery Life Sciences Funding
No funding data available
To view Rediscovery Life Sciences's complete valuation and funding history, request access »